Posted On: 01/28/2015 11:16:47 AM
Post# of 89342
$AKRX Headlines
Here are the best-performing stocks so far in 2015 11:47 a.m. Jan. 9, 2015 - Philip van Doorn
Time to play defense 1:53 p.m. Dec. 11, 2014 - The Trading Deck
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
Follow through is the key for speculators 1:05 p.m. Oct. 21, 2014 - The Trading Deck
Volume a sign of the Nasdaq’s weakened state 1:11 p.m. Oct. 7, 2014 - The Trading Deck
Speculators live by the sword, die by the sword 2:13 p.m. July 8, 2014 - The Trading Deck
Dow, Nasdaq nail the breakout point 9:36 a.m. June 27, 2014 - Michael Ashbaugh
From tiny Akorns grow mighty oaks? 10:03 a.m. Nov. 21, 2013 - The Trading Deck
Rail-Splitter's top small-cap bets are worth watching 11:34 a.m. Nov. 4, 2013 - Insider Monkey
Akorn to buy Hi-Tech for $640 million in cash 7:02 a.m. Aug. 27, 2013 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:20 p.m. July 23, 2012 - MarketWatch
Corrective bounce, or sustainable upturn? 9:59 a.m. June 6, 2012 - Michael Ashbaugh
Charting a bearish double top 11:11 a.m. May 15, 2012 - Michael Ashbaugh
Charting a bearish double top 10:45 a.m. May 15, 2012 - Michael Ashbaugh
Wednesday’s biggest gaining and declining stocks 5:02 p.m. March 7, 2012 - Sue Chang
Tuesday’s biggest gaining and declining stocks 4:23 p.m. March 6, 2012 - MarketWatch
Stocks to watch Tuesday: Nutrisystem, Jakks 7:00 a.m. March 6, 2012 - MarketWatch
S&P 500 scratches out three-year high 11:07 a.m. March 2, 2012 - Michael Ashbaugh
Stocks to watch Friday: LinkedIn, LeapFrog, Nuance 6:46 a.m. Feb. 10, 2012 - MarketWatch
S&P 500 vies for positive 2011 finish 11:09 a.m. Dec. 23, 2011 - Michael Ashbaugh
Lannett Early Q2 Earnings Beat Estimates; Stock Jumps 11:20 a.m. Jan. 26, 2015 - Investors Business Daily
Will New FDA Approvals Boost Leading Drug Stock Akorn? 11:01 a.m. Jan. 22, 2015 - Investors Business Daily
4 Screaming Growth Stocks to Buy 4:36 a.m. Jan. 22, 2015 - InvestorPlace.com
Jefferies Weighs In On Specialty Pharmaceuticals After Management Meetings, Raises Price Targets On 5 Stocks 12:00 p.m. Jan. 20, 2015 - benzinga.com
FDA clears Akorn ophthalmic solution 7:15 a.m. Jan. 20, 2015 - Seeking Alpha
US Stock Futures Surge Ahead Of Earnings 6:16 a.m. Jan. 20, 2015 - benzinga.com
Akorn Receives FDA Approval for Phenylephrine HCl Ophthalmic Solution 6:01 a.m. Jan. 20, 2015 - benzinga.com
Will Akorn (AKRX) Continue to Surge Higher? - Tale of the Tape 7:32 a.m. Jan. 19, 2015 - Zacks.com
5 Pharmaceutical Stocks to Buy Now 1:30 a.m. Jan. 16, 2015 - InvestorPlace.com
3 Reasons To Be Bullish On Generic Drug Firm Akorn 1:12 p.m. Jan. 15, 2015 - Investors Business Daily
Insider Trading Alert - BKD, AGX And AKRX Traded By Insiders 10:06 a.m. Jan. 13, 2015 - TheStreet.com
Akorn Sees Strong Pricing In Generic Drugs 4:51 p.m. Jan. 12, 2015 - Investors Business Daily
Biggest Upside Of Current Best Market-Maker Forecasts 9:43 p.m. Jan. 11, 2015 - Seeking Alpha
Week In Review: WuXi PharmaTech Pays $65 Million For Genomics Company 11:10 a.m. Jan. 11, 2015 - Seeking Alpha
Four Best Gains In IBD 50: Nothing To Do With Oil 5:35 p.m. Jan. 9, 2015 - Investors Business Daily
Weekly Review Shows Five Industries Gain In December 5:06 p.m. Jan. 8, 2015 - Investors Business Daily
Top 4 NASDAQ Stocks In The Drugs Generic Industry With The Highest EPS Growth Forecast For Next 5 Years 3:33 a.m. Dec. 29, 2014 - benzinga.com
Actavis' Alzheimer's Drug Approved; Bystolic Gets CRL - Analyst Blog 1:20 p.m. Dec. 26, 2014 - Zacks.com
Adamas Pharmaceuticals (ADMS) Jumps: Stock Gains 9.9% - Tale of the Tape 9:25 a.m. Dec. 26, 2014 - Zacks.com
Strength Seen in Parnell (PARN): Stock Moves 5.3% Higher - Tale of the Tape 9:25 a.m. Dec. 24, 2014 - Zacks.com
Akorn Set to Join the S&P MidCap 400; United Insurance Holdings, ANI Pharmaceuticals to Join the S&P SmallCap 600 5:46 p.m. Jan. 27, 2015 - PR Newswire - PRF
Pre-Market Pulse on Pharma Stocks - Teva Pharma Industries, Allergan, Endo Intl., Akorn, and Depomed 8:30 a.m. Jan. 16, 2015 - PR Newswire - PRF
Akorn Confirms Generic Durezol(R) Patent Challenge 5:30 p.m. Jan. 15, 2015 - GlobeNewswire
Akorn to Present at the 33rd Annual J.P. Morgan Healthcare Conference 9:30 a.m. Dec. 19, 2014 - GlobeNewswire
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
Akorn Reports Preliminary 2014 Third Quarter Results 7:31 a.m. Nov. 6, 2014 - GlobeNewswire
Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings 8:45 a.m. Nov. 3, 2014 - PR Newswire - PRF
Akorn, Inc. Announces Third Quarter 2014 Earnings Release and Conference Call Information 10:04 a.m. Oct. 21, 2014 - GlobeNewswire
Sunovion Pharmaceuticals Inc. to Divest Xopenex® (levalbuterol HCI) Inhalation Solution (IS) to Akorn, Inc. 3:22 p.m. Sept. 30, 2014 - BusinessWire - BZX
Akorn Acquires Xopenex(R) (levalbuterol HCI) Inhalation Solution From Sunovion 3:16 p.m. Sept. 30, 2014 - GlobeNewswire
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 8:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Restaurant Openings, Financial Releases, Completed Projects, Regulatory Updates, and Strategic Acquisitions - Research Reports on El Pollo Loco, SunEdison, Workday, PCG and Akorn 7:30 a.m. Sept. 5, 2014 - PR Newswire - PRF
Akorn Completes Acquisition of VersaPharm 7:51 a.m. Aug. 12, 2014 - GlobeNewswire
Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed 8:20 a.m. Aug. 7, 2014 - PR Newswire - PRF
Akorn Reports Preliminary 2014 Second Quarter Results 5:05 a.m. Aug. 5, 2014 - GlobeNewswire
Global Parkinson%s Disease Market 2014-2018 5:42 p.m. July 28, 2014 - PR Newswire - PRF
Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information 10:34 a.m. July 15, 2014 - GlobeNewswire
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 5:50 a.m. July 2, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 5:40 a.m. June 27, 2014 - PR Newswire - PRF
Akorn Divests ECR Pharmaceuticals to Valeant 10:11 a.m. June 20, 2014 - BusinessWire - BZX
Here are the best-performing stocks so far in 2015 11:47 a.m. Jan. 9, 2015 - Philip van Doorn
Time to play defense 1:53 p.m. Dec. 11, 2014 - The Trading Deck
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
Follow through is the key for speculators 1:05 p.m. Oct. 21, 2014 - The Trading Deck
Volume a sign of the Nasdaq’s weakened state 1:11 p.m. Oct. 7, 2014 - The Trading Deck
Speculators live by the sword, die by the sword 2:13 p.m. July 8, 2014 - The Trading Deck
Dow, Nasdaq nail the breakout point 9:36 a.m. June 27, 2014 - Michael Ashbaugh
From tiny Akorns grow mighty oaks? 10:03 a.m. Nov. 21, 2013 - The Trading Deck
Rail-Splitter's top small-cap bets are worth watching 11:34 a.m. Nov. 4, 2013 - Insider Monkey
Akorn to buy Hi-Tech for $640 million in cash 7:02 a.m. Aug. 27, 2013 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:20 p.m. July 23, 2012 - MarketWatch
Corrective bounce, or sustainable upturn? 9:59 a.m. June 6, 2012 - Michael Ashbaugh
Charting a bearish double top 11:11 a.m. May 15, 2012 - Michael Ashbaugh
Charting a bearish double top 10:45 a.m. May 15, 2012 - Michael Ashbaugh
Wednesday’s biggest gaining and declining stocks 5:02 p.m. March 7, 2012 - Sue Chang
Tuesday’s biggest gaining and declining stocks 4:23 p.m. March 6, 2012 - MarketWatch
Stocks to watch Tuesday: Nutrisystem, Jakks 7:00 a.m. March 6, 2012 - MarketWatch
S&P 500 scratches out three-year high 11:07 a.m. March 2, 2012 - Michael Ashbaugh
Stocks to watch Friday: LinkedIn, LeapFrog, Nuance 6:46 a.m. Feb. 10, 2012 - MarketWatch
S&P 500 vies for positive 2011 finish 11:09 a.m. Dec. 23, 2011 - Michael Ashbaugh
Lannett Early Q2 Earnings Beat Estimates; Stock Jumps 11:20 a.m. Jan. 26, 2015 - Investors Business Daily
Will New FDA Approvals Boost Leading Drug Stock Akorn? 11:01 a.m. Jan. 22, 2015 - Investors Business Daily
4 Screaming Growth Stocks to Buy 4:36 a.m. Jan. 22, 2015 - InvestorPlace.com
Jefferies Weighs In On Specialty Pharmaceuticals After Management Meetings, Raises Price Targets On 5 Stocks 12:00 p.m. Jan. 20, 2015 - benzinga.com
FDA clears Akorn ophthalmic solution 7:15 a.m. Jan. 20, 2015 - Seeking Alpha
US Stock Futures Surge Ahead Of Earnings 6:16 a.m. Jan. 20, 2015 - benzinga.com
Akorn Receives FDA Approval for Phenylephrine HCl Ophthalmic Solution 6:01 a.m. Jan. 20, 2015 - benzinga.com
Will Akorn (AKRX) Continue to Surge Higher? - Tale of the Tape 7:32 a.m. Jan. 19, 2015 - Zacks.com
5 Pharmaceutical Stocks to Buy Now 1:30 a.m. Jan. 16, 2015 - InvestorPlace.com
3 Reasons To Be Bullish On Generic Drug Firm Akorn 1:12 p.m. Jan. 15, 2015 - Investors Business Daily
Insider Trading Alert - BKD, AGX And AKRX Traded By Insiders 10:06 a.m. Jan. 13, 2015 - TheStreet.com
Akorn Sees Strong Pricing In Generic Drugs 4:51 p.m. Jan. 12, 2015 - Investors Business Daily
Biggest Upside Of Current Best Market-Maker Forecasts 9:43 p.m. Jan. 11, 2015 - Seeking Alpha
Week In Review: WuXi PharmaTech Pays $65 Million For Genomics Company 11:10 a.m. Jan. 11, 2015 - Seeking Alpha
Four Best Gains In IBD 50: Nothing To Do With Oil 5:35 p.m. Jan. 9, 2015 - Investors Business Daily
Weekly Review Shows Five Industries Gain In December 5:06 p.m. Jan. 8, 2015 - Investors Business Daily
Top 4 NASDAQ Stocks In The Drugs Generic Industry With The Highest EPS Growth Forecast For Next 5 Years 3:33 a.m. Dec. 29, 2014 - benzinga.com
Actavis' Alzheimer's Drug Approved; Bystolic Gets CRL - Analyst Blog 1:20 p.m. Dec. 26, 2014 - Zacks.com
Adamas Pharmaceuticals (ADMS) Jumps: Stock Gains 9.9% - Tale of the Tape 9:25 a.m. Dec. 26, 2014 - Zacks.com
Strength Seen in Parnell (PARN): Stock Moves 5.3% Higher - Tale of the Tape 9:25 a.m. Dec. 24, 2014 - Zacks.com
Akorn Set to Join the S&P MidCap 400; United Insurance Holdings, ANI Pharmaceuticals to Join the S&P SmallCap 600 5:46 p.m. Jan. 27, 2015 - PR Newswire - PRF
Pre-Market Pulse on Pharma Stocks - Teva Pharma Industries, Allergan, Endo Intl., Akorn, and Depomed 8:30 a.m. Jan. 16, 2015 - PR Newswire - PRF
Akorn Confirms Generic Durezol(R) Patent Challenge 5:30 p.m. Jan. 15, 2015 - GlobeNewswire
Akorn to Present at the 33rd Annual J.P. Morgan Healthcare Conference 9:30 a.m. Dec. 19, 2014 - GlobeNewswire
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
Akorn Reports Preliminary 2014 Third Quarter Results 7:31 a.m. Nov. 6, 2014 - GlobeNewswire
Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings 8:45 a.m. Nov. 3, 2014 - PR Newswire - PRF
Akorn, Inc. Announces Third Quarter 2014 Earnings Release and Conference Call Information 10:04 a.m. Oct. 21, 2014 - GlobeNewswire
Sunovion Pharmaceuticals Inc. to Divest Xopenex® (levalbuterol HCI) Inhalation Solution (IS) to Akorn, Inc. 3:22 p.m. Sept. 30, 2014 - BusinessWire - BZX
Akorn Acquires Xopenex(R) (levalbuterol HCI) Inhalation Solution From Sunovion 3:16 p.m. Sept. 30, 2014 - GlobeNewswire
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 8:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Restaurant Openings, Financial Releases, Completed Projects, Regulatory Updates, and Strategic Acquisitions - Research Reports on El Pollo Loco, SunEdison, Workday, PCG and Akorn 7:30 a.m. Sept. 5, 2014 - PR Newswire - PRF
Akorn Completes Acquisition of VersaPharm 7:51 a.m. Aug. 12, 2014 - GlobeNewswire
Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed 8:20 a.m. Aug. 7, 2014 - PR Newswire - PRF
Akorn Reports Preliminary 2014 Second Quarter Results 5:05 a.m. Aug. 5, 2014 - GlobeNewswire
Global Parkinson%s Disease Market 2014-2018 5:42 p.m. July 28, 2014 - PR Newswire - PRF
Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information 10:34 a.m. July 15, 2014 - GlobeNewswire
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 5:50 a.m. July 2, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 5:40 a.m. June 27, 2014 - PR Newswire - PRF
Akorn Divests ECR Pharmaceuticals to Valeant 10:11 a.m. June 20, 2014 - BusinessWire - BZX
(0)
(0)
